Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net loss $ (9,107) $ (22,044)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation and amortization 661 811
Stock-based compensation expense 770 862
Change in fair value of warrant liabilities (2,265) 1,253
Non-cash impairment of licensed technology 1,355
Non-cash impairment of right-of-use lease assets 1,561
Non-cash impairment of construction-in-progress 3,252
Accretion and interest on short-term investments (117) (84)
Amortization of right-of-use lease assets 227 302
Non-cash interest 100 200
Change in operating assets and liabilities:    
Accounts receivable 3,000
Other receivables (75)
Prepaid expenses and other current assets (1,199) 379
Other assets (56) 148
Accounts payable, accrued expenses and lease liabilities (684) (4,386)
Other current liabilities 1
Change in payable to licensor (296)
Net cash used in operating activities (11,744) (13,687)
Cash flows from investing activities:    
Capital expenditures (218) (103)
Purchases of short-term investments (7,964) (7,487)
Proceeds from maturities of short-term investments 10,393 8,665
Net cash provided by investing activities 2,211 1,075
Cash flows from financing activities:    
Payments made for net settlement of restricted share awards (4)
Net cash used in financing activities (4)
Net decrease in cash, cash equivalents and restricted cash (9,537) (12,612)
Cash, cash equivalents and restricted cash at beginning of period 14,555 38,829
Cash, cash equivalents and restricted cash at end of period 5,018 26,217
Supplemental cash flow information:    
Cash and cash equivalents 4,680 20,326
Restricted cash 338 5,891
Total cash, cash equivalents and restricted cash $ 5,018 $ 26,217